G Xu, D A Stoffers, J F Habener, S Bonner-Weir. Diabetes 1999
Times Cited: 950
Times Cited: 950
Times Cited
Times Co-cited
Similarity
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
14
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.
Alexandra E Butler, Juliette Janson, Susan Bonner-Weir, Robert Ritzel, Robert A Rizza, Peter C Butler. Diabetes 2003
Alexandra E Butler, Juliette Janson, Susan Bonner-Weir, Robert Ritzel, Robert A Rizza, Peter C Butler. Diabetes 2003
13
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
M A Nauck, M M Heimesaat, C Orskov, J J Holst, R Ebert, W Creutzfeldt. J Clin Invest 1993
M A Nauck, M M Heimesaat, C Orskov, J J Holst, R Ebert, W Creutzfeldt. J Clin Invest 1993
11
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
11
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.
Mette Zander, Sten Madsbad, Jan Lysgaard Madsen, Jens Juul Holst. Lancet 2002
Mette Zander, Sten Madsbad, Jan Lysgaard Madsen, Jens Juul Holst. Lancet 2002
10
Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans.
Juris J Meier, Alexandra E Butler, Yoshifumi Saisho, Travis Monchamp, Ryan Galasso, Anil Bhushan, Robert A Rizza, Peter C Butler. Diabetes 2008
Juris J Meier, Alexandra E Butler, Yoshifumi Saisho, Travis Monchamp, Ryan Galasso, Anil Bhushan, Robert A Rizza, Peter C Butler. Diabetes 2008
9
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
Daniel J Drucker, Michael A Nauck. Lancet 2006
Daniel J Drucker, Michael A Nauck. Lancet 2006
9
Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice.
Shuen-Ing Tschen, Sangeeta Dhawan, Tatyana Gurlo, Anil Bhushan. Diabetes 2009
Shuen-Ing Tschen, Sangeeta Dhawan, Tatyana Gurlo, Anil Bhushan. Diabetes 2009
9
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Yazhou Li, Tanya Hansotia, Bernardo Yusta, Frederic Ris, Philippe A Halban, Daniel J Drucker. J Biol Chem 2003
Yazhou Li, Tanya Hansotia, Bernardo Yusta, Frederic Ris, Philippe A Halban, Daniel J Drucker. J Biol Chem 2003
9
Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
C Tourrel, D Bailbé, M J Meile, M Kergoat, B Portha. Diabetes 2001
C Tourrel, D Bailbé, M J Meile, M Kergoat, B Portha. Diabetes 2001
9
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.
B Thorens. Proc Natl Acad Sci U S A 1992
B Thorens. Proc Natl Acad Sci U S A 1992
9
Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.
Michael Elashoff, Aleksey V Matveyenko, Belinda Gier, Robert Elashoff, Peter C Butler. Gastroenterology 2011
Michael Elashoff, Aleksey V Matveyenko, Belinda Gier, Robert Elashoff, Peter C Butler. Gastroenterology 2011
9
Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells.
Elizabeth J Abraham, Colin A Leech, Julia C Lin, Henryk Zulewski, Joel F Habener. Endocrinology 2002
Elizabeth J Abraham, Colin A Leech, Julia C Lin, Henryk Zulewski, Joel F Habener. Endocrinology 2002
9
Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.
Yuval Dor, Juliana Brown, Olga I Martinez, Douglas A Melton. Nature 2004
Yuval Dor, Juliana Brown, Olga I Martinez, Douglas A Melton. Nature 2004
8
Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
8
Pharmacology, physiology, and mechanisms of incretin hormone action.
Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
Jonathan E Campbell, Daniel J Drucker. Cell Metab 2013
8
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects.
C F Deacon, M A Nauck, M Toft-Nielsen, L Pridal, B Willms, J J Holst. Diabetes 1995
C F Deacon, M A Nauck, M Toft-Nielsen, L Pridal, B Willms, J J Holst. Diabetes 1995
8
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
Steven E Kahn, Steven M Haffner, Mark A Heise, William H Herman, Rury R Holman, Nigel P Jones, Barbara G Kravitz, John M Lachin, M Colleen O'Neill, Bernard Zinman,[...]. N Engl J Med 2006
Steven E Kahn, Steven M Haffner, Mark A Heise, William H Herman, Rury R Holman, Nigel P Jones, Barbara G Kravitz, John M Lachin, M Colleen O'Neill, Bernard Zinman,[...]. N Engl J Med 2006
7
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Loredana Farilla, Angela Bulotta, Boaz Hirshberg, Sergio Li Calzi, Nasif Khoury, Houtan Noushmehr, Cristina Bertolotto, Umberto Di Mario, David M Harlan, Riccardo Perfetti. Endocrinology 2003
Loredana Farilla, Angela Bulotta, Boaz Hirshberg, Sergio Li Calzi, Nasif Khoury, Houtan Noushmehr, Cristina Bertolotto, Umberto Di Mario, David M Harlan, Riccardo Perfetti. Endocrinology 2003
7
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.
M A Nauck, N Kleine, C Orskov, J J Holst, B Willms, W Creutzfeldt. Diabetologia 1993
M A Nauck, N Kleine, C Orskov, J J Holst, B Willms, W Creutzfeldt. Diabetologia 1993
7
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.
C F Deacon, A H Johnsen, J J Holst. J Clin Endocrinol Metab 1995
C F Deacon, A H Johnsen, J J Holst. J Clin Endocrinol Metab 1995
7
Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.
D A Stoffers, T J Kieffer, M A Hussain, D J Drucker, S Bonner-Weir, J F Habener, J M Egan. Diabetes 2000
D A Stoffers, T J Kieffer, M A Hussain, D J Drucker, S Bonner-Weir, J F Habener, J M Egan. Diabetes 2000
7
Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes.
Mathijs C Bunck, Anja Cornér, Bjorn Eliasson, Robert J Heine, Rimma M Shaginian, Marja-Riitta Taskinen, Ulf Smith, Hannele Yki-Järvinen, Michaela Diamant. Diabetes Care 2011
Mathijs C Bunck, Anja Cornér, Bjorn Eliasson, Robert J Heine, Rimma M Shaginian, Marja-Riitta Taskinen, Ulf Smith, Hannele Yki-Järvinen, Michaela Diamant. Diabetes Care 2011
7
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen,[...]. N Engl J Med 2015
Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen,[...]. N Engl J Med 2015
7
Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system.
P L Brubaker, D J Drucker. Endocrinology 2004
P L Brubaker, D J Drucker. Endocrinology 2004
6
Pancreatic beta-cell mass in European subjects with type 2 diabetes.
J Rahier, Y Guiot, R M Goebbels, C Sempoux, J C Henquin. Diabetes Obes Metab 2008
J Rahier, Y Guiot, R M Goebbels, C Sempoux, J C Henquin. Diabetes Obes Metab 2008
6
6
Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendin.
Maarten Brom, Wietske Woliner-van der Weg, Lieke Joosten, Cathelijne Frielink, Thomas Bouckenooghe, Paul Rijken, Karolina Andralojc, Burkhard J Göke, Marion de Jong, Decio L Eizirik,[...]. Diabetologia 2014
Maarten Brom, Wietske Woliner-van der Weg, Lieke Joosten, Cathelijne Frielink, Thomas Bouckenooghe, Paul Rijken, Karolina Andralojc, Burkhard J Göke, Marion de Jong, Decio L Eizirik,[...]. Diabetologia 2014
6
Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.
P J Larsen, M Tang-Christensen, J J Holst, C Orskov. Neuroscience 1997
P J Larsen, M Tang-Christensen, J J Holst, C Orskov. Neuroscience 1997
6
Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.
S Mojsov, G C Weir, J F Habener. J Clin Invest 1987
S Mojsov, G C Weir, J F Habener. J Clin Invest 1987
6
The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action.
Kristine J Hare, Tina Vilsbøll, Meena Asmar, Carolyn F Deacon, Filip K Knop, Jens J Holst. Diabetes 2010
Kristine J Hare, Tina Vilsbøll, Meena Asmar, Carolyn F Deacon, Filip K Knop, Jens J Holst. Diabetes 2010
6
Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.
Belinda Gier, Aleksey V Matveyenko, David Kirakossian, David Dawson, Sarah M Dry, Peter C Butler. Diabetes 2012
Belinda Gier, Aleksey V Matveyenko, David Kirakossian, David Dawson, Sarah M Dry, Peter C Butler. Diabetes 2012
6
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis,[...]. N Engl J Med 2015
Marc A Pfeffer, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Lars V Køber, Francesca C Lawson, Lin Ping, Xiaodan Wei, Eldrin F Lewis,[...]. N Engl J Med 2015
6
The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice.
Bidda Rolin, Marianne O Larsen, Carsten F Gotfredsen, Carolyn F Deacon, Richard D Carr, Michael Wilken, Lotte Bjerre Knudsen. Am J Physiol Endocrinol Metab 2002
Bidda Rolin, Marianne O Larsen, Carsten F Gotfredsen, Carolyn F Deacon, Richard D Carr, Michael Wilken, Lotte Bjerre Knudsen. Am J Physiol Endocrinol Metab 2002
6
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus.
Juris J Meier. Nat Rev Endocrinol 2012
Juris J Meier. Nat Rev Endocrinol 2012
6
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Rury R Holman, M Angelyn Bethel, Robert J Mentz, Vivian P Thompson, Yuliya Lokhnygina, John B Buse, Juliana C Chan, Jasmine Choi, Stephanie M Gustavson, Nayyar Iqbal,[...]. N Engl J Med 2017
Rury R Holman, M Angelyn Bethel, Robert J Mentz, Vivian P Thompson, Yuliya Lokhnygina, John B Buse, Juliana C Chan, Jasmine Choi, Stephanie M Gustavson, Nayyar Iqbal,[...]. N Engl J Med 2017
6
Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.
Lotte Bjerre Knudsen, Lars Wichmann Madsen, Søren Andersen, Kasper Almholt, Anne S de Boer, Daniel J Drucker, Carsten Gotfredsen, Frederikke Lihme Egerod, Anne Charlotte Hegelund, Helene Jacobsen,[...]. Endocrinology 2010
Lotte Bjerre Knudsen, Lars Wichmann Madsen, Søren Andersen, Kasper Almholt, Anne S de Boer, Daniel J Drucker, Carsten Gotfredsen, Frederikke Lihme Egerod, Anne Charlotte Hegelund, Helene Jacobsen,[...]. Endocrinology 2010
6
A role for glucagon-like peptide-1 in the central regulation of feeding.
M D Turton, D O'Shea, I Gunn, S A Beak, C M Edwards, K Meeran, S J Choi, G M Taylor, M M Heath, P D Lambert,[...]. Nature 1996
M D Turton, D O'Shea, I Gunn, S A Beak, C M Edwards, K Meeran, S J Choi, G M Taylor, M M Heath, P D Lambert,[...]. Nature 1996
6
GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
Charles Pyke, R Scott Heller, Rikke K Kirk, Cathrine Ørskov, Steffen Reedtz-Runge, Peter Kaastrup, Anders Hvelplund, Linda Bardram, Dan Calatayud, Lotte Bjerre Knudsen. Endocrinology 2014
Charles Pyke, R Scott Heller, Rikke K Kirk, Cathrine Ørskov, Steffen Reedtz-Runge, Peter Kaastrup, Anders Hvelplund, Linda Bardram, Dan Calatayud, Lotte Bjerre Knudsen. Endocrinology 2014
6
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
Q Wang, P L Brubaker. Diabetologia 2002
Q Wang, P L Brubaker. Diabetologia 2002
5
One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.
Kristine B Degn, Claus B Juhl, Jeppe Sturis, Grethe Jakobsen, Birgitte Brock, Visvanathan Chandramouli, Joergen Rungby, Bernard R Landau, Ole Schmitz. Diabetes 2004
Kristine B Degn, Claus B Juhl, Jeppe Sturis, Grethe Jakobsen, Birgitte Brock, Visvanathan Chandramouli, Joergen Rungby, Bernard R Landau, Ole Schmitz. Diabetes 2004
5
Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss.
Fabrizio Thorel, Virginie Népote, Isabelle Avril, Kenji Kohno, Renaud Desgraz, Simona Chera, Pedro L Herrera. Nature 2010
Fabrizio Thorel, Virginie Népote, Isabelle Avril, Kenji Kohno, Renaud Desgraz, Simona Chera, Pedro L Herrera. Nature 2010
5
The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.
Lise L Kjems, Jens J Holst, Aage Vølund, Sten Madsbad. Diabetes 2003
Lise L Kjems, Jens J Holst, Aage Vølund, Sten Madsbad. Diabetes 2003
5
Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications.
Michael A Nauck. Am J Med 2011
Michael A Nauck. Am J Med 2011
5
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
T Vilsbøll, F K Knop, T Krarup, A Johansen, S Madsbad, S Larsen, T Hansen, O Pedersen, J J Holst. J Clin Endocrinol Metab 2003
T Vilsbøll, F K Knop, T Krarup, A Johansen, S Madsbad, S Larsen, T Hansen, O Pedersen, J J Holst. J Clin Endocrinol Metab 2003
5
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.
Orville G Kolterman, Dennis D Kim, Larry Shen, James A Ruggles, Loretta L Nielsen, Mark S Fineman, Alain D Baron. Am J Health Syst Pharm 2005
Orville G Kolterman, Dennis D Kim, Larry Shen, James A Ruggles, Loretta L Nielsen, Mark S Fineman, Alain D Baron. Am J Health Syst Pharm 2005
5
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.
Brian Finan, Bin Yang, Nickki Ottaway, David L Smiley, Tao Ma, Christoffer Clemmensen, Joe Chabenne, Lianshan Zhang, Kirk M Habegger, Katrin Fischer,[...]. Nat Med 2015
Brian Finan, Bin Yang, Nickki Ottaway, David L Smiley, Tao Ma, Christoffer Clemmensen, Joe Chabenne, Lianshan Zhang, Kirk M Habegger, Katrin Fischer,[...]. Nat Med 2015
5
Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.
D J Drucker, J Philippe, S Mojsov, W L Chick, J F Habener. Proc Natl Acad Sci U S A 1987
D J Drucker, J Philippe, S Mojsov, W L Chick, J F Habener. Proc Natl Acad Sci U S A 1987
5
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.